Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jul 6;4(11):948–955. doi: 10.1016/j.bpsc.2019.06.012

Figure 3.

Figure 3.

Regions of Interest for PET scan registration. Asterisk (*) indicates regions with statistically significant BP MAOA-fluoxetine interactions and significant post-hoc comparisons of fluoxetine and control groups in the low-MAOA subgroup (see Table 1).